WO2003065979A3 - Procedes de diagnostic, de controle et de traitement de la sterilite - Google Patents

Procedes de diagnostic, de controle et de traitement de la sterilite Download PDF

Info

Publication number
WO2003065979A3
WO2003065979A3 PCT/US2002/038629 US0238629W WO03065979A3 WO 2003065979 A3 WO2003065979 A3 WO 2003065979A3 US 0238629 W US0238629 W US 0238629W WO 03065979 A3 WO03065979 A3 WO 03065979A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
fertility
diagnosis
treatment
monitoring
Prior art date
Application number
PCT/US2002/038629
Other languages
English (en)
Other versions
WO2003065979A2 (fr
Inventor
Yousef Ai-Abed
Original Assignee
Long Island Jewish Res Inst
Yousef Ai-Abed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Long Island Jewish Res Inst, Yousef Ai-Abed filed Critical Long Island Jewish Res Inst
Priority to AU2002365941A priority Critical patent/AU2002365941A1/en
Publication of WO2003065979A2 publication Critical patent/WO2003065979A2/fr
Publication of WO2003065979A3 publication Critical patent/WO2003065979A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention porte en général sur des procédés d'utilisation de l'activité de la tautomérase dopachrome du facteur inhibiteur de la migration des macrophages et sur des protéines apparentées ou autres protéines présentes dans le liquide séminal (éjaculat) d'un mâle afin d'évaluer la stérilité et autres pathologies apparentées. L'invention porte également sur le diagnostic et le traitement de la stérilité, sur de nouvelles méthodes contraceptives et sur des procédés visant à améliorer l'insémination artificielle et la fécondation in vitro.
PCT/US2002/038629 2001-12-05 2002-12-05 Procedes de diagnostic, de controle et de traitement de la sterilite WO2003065979A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365941A AU2002365941A1 (en) 2001-12-05 2002-12-05 Methods of diagnosis, monitoring and treatment of fertility

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35575501P 2001-12-05 2001-12-05
US60/355,755 2001-12-05

Publications (2)

Publication Number Publication Date
WO2003065979A2 WO2003065979A2 (fr) 2003-08-14
WO2003065979A3 true WO2003065979A3 (fr) 2004-02-12

Family

ID=27734557

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/038629 WO2003065979A2 (fr) 2001-12-05 2002-12-05 Procedes de diagnostic, de controle et de traitement de la sterilite

Country Status (2)

Country Link
AU (1) AU2002365941A1 (fr)
WO (1) WO2003065979A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
CA2600175A1 (fr) 2005-03-24 2006-03-20 Avanir Pharmaceuticals Derives de thienopyridinone utilises en tant qu'inhibiteurs du facteur d'inhibition de la migration des macrophages
WO2007044622A1 (fr) * 2005-10-07 2007-04-19 Yale University Utilisation de mif et d'agonistes de la voie mif
ES2620506T3 (es) * 2009-06-17 2017-06-28 Hiroshima University Disolución diluyente de esperma y método para inseminación artificial usando la misma
US20150359763A1 (en) * 2013-01-30 2015-12-17 Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada Use of 3-bromopyruvate as a contraceptive

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420188B1 (en) * 1996-02-16 2002-07-16 The Picower Institute For Medical Research Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
US6492428B1 (en) * 2000-07-26 2002-12-10 The Picower Institute For Medical Research Compounds having MIF antagonist activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420188B1 (en) * 1996-02-16 2002-07-16 The Picower Institute For Medical Research Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
US6492428B1 (en) * 2000-07-26 2002-12-10 The Picower Institute For Medical Research Compounds having MIF antagonist activity

Also Published As

Publication number Publication date
AU2002365941A1 (en) 2003-09-02
AU2002365941A8 (en) 2003-09-02
WO2003065979A2 (fr) 2003-08-14

Similar Documents

Publication Publication Date Title
CA2442341A1 (fr) Dispositifs et methodes d'identification, de caracterisation et d'occlusion des arteres uterines multiaxiales
DE60237431D1 (de) Rezeptor-selektive cannabimimetische aminoalkylindole
NO985701L (no) Biokompatibelt lim
EA199901107A1 (ru) Системы и устройства для лечения переломов костей или больных костей с помощью расширяемых тел (варианты), стерильный набор инструментов для введения в кость (варианты)
WO2004077922A3 (fr) Ecarteur eclairable
CO5280226A1 (es) Tratamiento enzimatico
BRPI0414215A (pt) tienopirazóis
HK1106990A1 (en) Connecting member insertable inside a bone structure of a human or animal body, and related locating system
PT1091747E (pt) Utilizacao de solucoes salinas isotermicas para a prevencao de inflamacoes
DE69942959D1 (de) Pferdesystem für die künstliche Befruchtung ohne chirurgischen Eingriff
DE69930335D1 (de) Vorrichtung für die Chirurgie der Hornhaut
AU2002252225A1 (en) Physiological monitor for veterinary and human medical use and method
DE60122672D1 (de) Zusammensetzung zur intestinalen verabreichung
WO2003065979A3 (fr) Procedes de diagnostic, de controle et de traitement de la sterilite
CA2286710A1 (fr) Dispositif d'insemination artificielle pour animaux d'elevage tels que, notamment, truies______________________________________________________
ATE296607T1 (de) Zubereitung zur entfernung von abnormen keratinmaterial
WO2003022993A3 (fr) Procedes relatifs a l'elaboration de modeles ex vivo pour maladies inflammatoires, et utilisations correspondantes
AU2003259796A1 (en) Protection of the female reproductive system from natural and artificial insults
Howard et al. Concepts in orbital reconstruction
BR0308795A (pt) Amidas do ácido sulfamico
NO992902D0 (no) Diagnostiske mark°rer for humane sykdommer
CA2151476A1 (fr) Utilisation d'inhibiteurs de la cyclo-oxygenase dans la fabrication d'un medicament ameliorant l'irrigation sanguine de l'uterus
AU2002352089A1 (en) Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis
AU2002316158A1 (en) Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents
PT1105503E (pt) Guanililciclase humana soluvel alfal/betal (hsgc alfal/betal) isolada e purificada

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP